OptimizeRx

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OptimizeRx and other ETFs, options, and stocks.

About OPRX

OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. 

CEO
Stephen L. Silvestro
CEOStephen L. Silvestro
Employees
133
Employees133
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
1985
Founded1985
Employees
133
Employees133

OPRX Key Statistics

Market cap
137.31M
Market cap137.31M
Price-Earnings ratio
28.52
Price-Earnings ratio28.52
Dividend yield
—
Dividend yield—
Average volume
345.41K
Average volume345.41K
High today
$8.69
High today$8.69
Low today
$7.23
Low today$7.23
Open price
$8.43
Open price$8.43
Volume
610.70K
Volume610.70K
52 Week high
$15.59
52 Week high$15.59
52 Week low
$4.54
52 Week low$4.54

Stock Snapshot

The current OptimizeRx(OPRX) stock price is $7.34, with a market capitalization of 137.31M. The stock trades at a price-to-earnings (P/E) ratio of 28.52.

As of 2026-11-16, OptimizeRx(OPRX) stock has fluctuated between $7.23 and $8.69. The current price stands at $7.34, placing the stock +1.6% above today's low and -15.5% off the high.

The OptimizeRx(OPRX)'s current trading volume is 610.7K, compared to an average daily volume of 345.41K.

In the last year, OptimizeRx(OPRX) shares hit a 52-week high of $15.59 and a 52-week low of $4.54.

In the last year, OptimizeRx(OPRX) shares hit a 52-week high of $15.59 and a 52-week low of $4.54.

OPRX News

TipRanks 1d
OptimizeRx Earnings Call Shows Margin Strength, Revenue Pressure

Optimizerx Corporation ((OPRX)) has held its Q3 earnings call. Read on for the main highlights of the call. OptimizeRx delivered a mixed but cautiously constru...

Simply Wall St 1d
OptimizeRx Fell 52%, But The Story Isn't Over - Simply Wall St

...

OptimizeRx Fell 52%, But The Story Isn't Over - Simply Wall St
Benzinga 4d
These Analysts Cut Their Forecasts On OptimizeRx After Q3 Results

OptimizeRx Corporation (NASDAQ:OPRX) reported upbeat earnings for the third quarter, but lowered its sales guidance on Wednesday. The company posted quarterly...

These Analysts Cut Their Forecasts On OptimizeRx After Q3 Results

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

More OPRX News

TipRanks 4d
OptimizeRx reports Q3 EPS 20c, consensus 16c

Reports Q3 revenue $21.62M, consensus $21.19M. Stephen Silvestro, OptimizeRx (OPRX) CEO commented, “Third quarter revenue and adjusted EBITDA both exceeded cons...

Seeking Alpha 4d
OptimizeRx Non-GAAP EPS of $0.20 beats by $0.04, revenue of $21.6M beats by $0.41M

Earnings News OptimizeRx Non-GAAP EPS of $0.20 beats by $0.04, revenue of $21.6M beats by $0.41M Nov 11, 2026, 4:05 PM ET OptimizeRx Corporation (OPRX) Stock By...

OptimizeRx Non-GAAP EPS of $0.20 beats by $0.04, revenue of $21.6M beats by $0.41M

People also own

Based on the portfolios of people who own OPRX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.